Pages that link to "Q36855792"

The following pages link to Targeting CCK receptors in human cancers (Q36855792):

Displaying 20 items.

• Positron emission tomography imaging of prostate cancer (Q24596241) (← links)
• Peptide-based probes for targeted molecular imaging (Q33526620) (← links)
• Peptides and peptide hormones for molecular imaging and disease diagnosis (Q33846924) (← links)
• CCK(2) receptor splice variant with intron 4 retention in human gastrointestinal and lung tumours (Q33925682) (← links)
• Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential (Q34712671) (← links)
• The global landscape of intron retentions in lung adenocarcinoma (Q35124798) (← links)
• Cancer treatment using peptides: current therapies and future prospects (Q36515785) (← links)
• Synthesis and in vitro characterization of radioiodinatable benzodiazepines selective for type 1 and type 2 cholecystokinin receptors (Q37152806) (← links)
• Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors (Q37278402) (← links)
• Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine (Q37644025) (← links)
• Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway (Q37672085) (← links)
• Radiometallated peptides for molecular imaging and targeted therapy. (Q37847064) (← links)
• Design and evaluation of radiolabeled tracers for tumor imaging (Q38137253) (← links)
• 177Lu Labeled Cyclic Minigastrin Analogues with Therapeutic Activity in CCK2R Expressing Tumors: Preclinical Evaluation of a Kit Formulation. (Q38696739) (← links)
• Preclinical evaluation of radiolabeled DOTA-derivatized cyclic minigastrin analogs for targeting cholecystokinin receptor expressing malignancies. (Q39512185) (← links)
• Role of radiopharmaceuticals in the diagnosis and treatment of neuroendocrine tumours (Q39944711) (← links)
• Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis. (Q54301320) (← links)
• Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m (Q64230471) (← links)
• Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes (Q90639198) (← links)
• Medullary Thyroid Carcinoma: An Update on Imaging (Q92278409) (← links)